{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:12:14Z","timestamp":1762431134237,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annallergy.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.anai.2016.03.012","type":"journal-article","created":{"date-parts":[[2016,3,24]],"date-time":"2016-03-24T04:03:54Z","timestamp":1458792234000},"page":"577-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Rivaroxaban-induced leukocytoclastic vasculitis"],"prefix":"10.1016","volume":"116","author":[{"given":"Gerard","family":"Chaaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Jaller-Char","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ejaz","family":"Ghaffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Analia","family":"Castiglioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2016.03.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.anai.2016.03.012_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40257-014-0076-6","article-title":"A\u00a0practical approach to the diagnosis, evaluation, and management of cutaneous small-vessel vasculitis","volume":"15","author":"Goeser","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.anai.2016.03.012_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-4632.2005.02898.x","article-title":"Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment","volume":"45","author":"Russell","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.anai.2016.03.012_bib4","first-page":"1604","article-title":"Leukocytoclastic vasculitis after injection of low-molecular-weight heparin [letter]","volume":"29","author":"de Bats","year":"2000","journal-title":"Presse Med"},{"key":"10.1016\/j.anai.2016.03.012_bib5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2169\/internalmedicine.51.6240","article-title":"Warfarin-induced leukocytoclastic vasculitis: a case report and review of literature","volume":"51","author":"Hsu","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.anai.2016.03.012_bib6","doi-asserted-by":"crossref","first-page":"616109","DOI":"10.1155\/2015\/616109","article-title":"Dabigatran associated leukocytoclastic vasculitis","volume":"2015","author":"Potolidis","year":"2015","journal-title":"Case Rep Med"},{"key":"10.1016\/j.anai.2016.03.012_bib7","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.clindermatol.2006.07.007","article-title":"Cutaneous vasculitis: diagnosis and management","volume":"24","author":"Carlson","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.anai.2016.03.012_bib8","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.thromres.2010.09.008","article-title":"The mechanism of action of rivaroxaban \u2013 an oral, direct Factor Xa inhibitor \u2013 compared with other anticoagulants","volume":"127","author":"Samama","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.anai.2016.03.012_bib9","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/ATVBAHA.115.303397","article-title":"Overview of the new oral anticoagulants opportunities and challenges","volume":"35","author":"Yeh","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.anai.2016.03.012_bib10","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1007\/s10620-014-3504-9","article-title":"Severe drug-induced skin and liver injury from rivaroxaban","volume":"60","author":"Barrett","year":"2015","journal-title":"Dig Dis Sci"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120616300503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120616300503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T13:15:19Z","timestamp":1761052519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120616300503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1081120616300503"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2016.03.012","relation":{},"ISSN":["1081-1206"],"issn-type":[{"type":"print","value":"1081-1206"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rivaroxaban-induced leukocytoclastic vasculitis","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2016.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}